Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WEE2 pseudogene 1 (WEE2P1) is a pseudogene and does not code for a functional protein. It is named in reference to WEE2, an oocyte-specific protein tyrosine kinase involved in meiotic cell cycle regulation, but WEE2P1 itself does not have an established biological function, does not serve as a therapeutic target, and is not implicated in disease or pharmacology. No drugs, disease associations, or mechanisms of action are described for WEE2P1. The presence of WEE2P1 is noted as a genomic sequence with similarity to WEE2, lacking functional protein-coding capacity[4]. Key details: - This entry refers to a pseudogene, not to the active WEE2 kinase gene or protein. - WEE2P1 is not a therapeutic target, does not encode a receptor, enzyme, or any functional protein, and has no described role in disease or drug interaction[4]. - If you are seeking information on the active kinase, refer instead to "WEE2 oocyte meiosis inhibiting kinase" (WEE2)[2][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WEE2 pseudogene 1 (WEE2P1).